Evidence map›Paper›PMID 42584544›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Versatile Co-Engineering of Immunogenic Cell Death-Primed Dead Tumor Cell Bodies With Tumor-Activated MnO

Bolun Xu, Xuan Lu, Yuquan Wang, Haihua Ji, Ying Zhang, Yiqun Wan, Hao Wan

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bolun XuSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China.
Xuan LuState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China.ORCID https://orcid.org/0009-0009-8258-5535
Yuquan WangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China.
Haihua JiState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China.
Ying ZhangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, P. R. China.ORCID https://orcid.org/0000-0001-6019-3498
Yiqun WanSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China.ORCID https://orcid.org/0000-0001-9596-6163
Hao WanSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang, P. R. China.ORCID https://orcid.org/0000-0002-9990-2359

Funding

Central Guidance Fund for Local Science and Technology Development in Jiangxi Province 20252ZDD020002National Natural Science Foundation of China 32372322National Natural Science Foundation of China 82503553Natural Science Foundation of Jiangxi Province 20224ACB215009Natural Science Foundation of Jiangxi Province 20232ACB205024Natural Science Foundation of Jiangxi Province 20242BAB21029Research Project of State Key Laboratory of Food Science and Resources SKLF-ZZB-202529Young Talent Cultivation Program of Nanchang University XX202506030014
6 · The paper itself

Abstract

Immunogenic cell death (ICD)-based whole-cell personalized cancer immunotherapies present full tumor antigens but suffer from poor immunogenicity, early clearance, and a glutathione (GSH)-rich immunosuppressive tumor microenvironment (TME). Here, we report a TME-responsive immunotherapeutic platform, DTBEI@CS@MnO

Indexed as

cGAS‐STING pathway activationdead tumor cell bodiesimmunogenic cell deathpersonalized cancer immunotherapytumor microenvironment responsiveness

Identifiers

PMID42584544
PMCPMC13464454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.